Cullinan Therapeutics (CGEM) FCF Margin (2021)
Cullinan Therapeutics has reported FCF Margin over the past 1 years, most recently at 8.0% for Q1 2021.
- Quarterly results put FCF Margin at 8.0% for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was 229.28% (changed N/A YoY), and the annual figure for FY2021 was 229.28%, changed.
- FCF Margin for Q1 2021 was 8.0% at Cullinan Therapeutics.
- Over the last five years, FCF Margin for CGEM hit a ceiling of 8.0% in Q1 2021 and a floor of 8.0% in Q1 2021.